Connectyx Announces Key Biotech Industry Veterans to Management Team
Expertise in Clinical Development, Regulatory Affairs and Manufacturing Represented
News provided by
Share this article
Share this article
BOCA RATON, Fla., Feb. 11, 2021 /PRNewswire/ -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) ("Connectyx" or the "Company"), Connectyx announced today the addition of three industry veterans to the company's management team. I Richard Garr will be joining the Company as chief executive officer and general counsel, Ron Bordens Ph.D. has been named executive vice president of technical operations and manufacturing, and Michael Grace Ph.D. has agreed to become chairman of the scientific advisory board. Paul M. Michaels will continue as executive chairman and president of Connectyx; and Dr. Barry Ginsberg will continue as vice chairman and chief strategy officer.